121 related articles for article (PubMed ID: 31220406)
1. Gene and protein delivery using four cell penetrating peptides for HIV-1 vaccine development.
Rostami B; Irani S; Bolhassani A; Cohan RA
IUBMB Life; 2019 Oct; 71(10):1619-1633. PubMed ID: 31220406
[TBL] [Abstract][Full Text] [Related]
2. M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines.
Rostami B; Irani S; Bolhassani A; Cohan RA
Curr HIV Res; 2018; 16(4):280-287. PubMed ID: 30520377
[TBL] [Abstract][Full Text] [Related]
3. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.
Kadkhodayan S; Jafarzade BS; Sadat SM; Motevalli F; Agi E; Bolhassani A
Immunol Lett; 2017 Aug; 188():38-45. PubMed ID: 28602843
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K; Hashemi A; Bolhassani A
Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753
[TBL] [Abstract][Full Text] [Related]
5. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate.
Davoodi S; Bolhassani A; Namazi F
Biotechnol Lett; 2021 Mar; 43(3):547-559. PubMed ID: 33386500
[TBL] [Abstract][Full Text] [Related]
6. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
[TBL] [Abstract][Full Text] [Related]
7. Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides.
Davoodi S; Bolhassani A; Sadat SM; Irani S
Biotechnol Lett; 2019 Nov; 41(11):1283-1298. PubMed ID: 31531750
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides.
Kardani K; Hashemi A; Bolhassani A
PLoS One; 2019; 14(10):e0223844. PubMed ID: 31671105
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses.
Alizadeh S; Irani S; Bolhassani A; Sadat SM
Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies.
Namazi F; Davoodi S; Bolhassani A
Curr Drug Deliv; 2022; 19(1):142-156. PubMed ID: 33655833
[TBL] [Abstract][Full Text] [Related]
11. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
Shahbazi S; Bolhassani A
Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237
[TBL] [Abstract][Full Text] [Related]
12. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
[TBL] [Abstract][Full Text] [Related]
13.
Shabani SH; Kardani K; Milani A; Bolhassani A
Immunol Invest; 2022 Jan; 51(1):1-28. PubMed ID: 33416004
[No Abstract] [Full Text] [Related]
14. Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells.
Namazi F; Bolhassani A; Sadat SM; Irani S
Curr HIV Res; 2019; 17(6):408-428. PubMed ID: 31755394
[TBL] [Abstract][Full Text] [Related]
15. B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs.
Kardani K; Bolhassani A; Agi E; Hashemi A
Biotechnol Lett; 2020 Oct; 42(10):1847-1863. PubMed ID: 32449070
[TBL] [Abstract][Full Text] [Related]
16. LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice.
Nikyar A; Bolhassani A; Agi E
Biotechnol Lett; 2023 Jan; 45(1):33-45. PubMed ID: 36550339
[TBL] [Abstract][Full Text] [Related]
17. Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model.
Jafarzade BS; Sadat SM; Yaghobi R; Bolhassani A
Bratisl Lek Listy; 2017; 118(9):564-569. PubMed ID: 29061065
[TBL] [Abstract][Full Text] [Related]
18. Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes.
Akbari E; Ajdary S; Mirabzadeh Ardakani E; Agi E; Milani A; Seyedinkhorasani M; Khalaj V; Bolhassani A
Pathog Dis; 2022 Jul; 80(1):. PubMed ID: 35704612
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter.
Cazeaux N; Bennasser Y; Vidal PL; Li Z; Paulin D; Bahraoui E
Vaccine; 2002 Sep; 20(27-28):3322-31. PubMed ID: 12213402
[TBL] [Abstract][Full Text] [Related]
20. Effective Delivery of Nef-MPER-V3 Fusion Protein Using LDP12 Cell Penetrating Peptide for Development of Preventive/Therapeutic HIV-1 Vaccine.
Sabaghzadeh S; Sadat SM; Rohollah F; Bolhassani A
Protein Pept Lett; 2020; 27(11):1151-1158. PubMed ID: 32364062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
